Abstracts

Filters

Clear Filters
All Days Sun, Sep 27 Mon, Sep 28 Tue, Sep 29 Wed, Sep 30

Monday, September 28

8:35 AM - 8:55 AM ET

Questions & Answers
Speaker: Pollom, Erqi, MD, MS - Stanford Cancer Institute Palo Alto, Stanford, CA
8:40 AM - 8:50 AM ET

153 - Alternative Cancer Treatment Clinics in North America: Evidence Gaps, Regulatory Concerns, and Financial Burden
Speaker: El Kouzi, Zakaria, MD - MD Anderson Cancer Center, Houston, TX
8:40 AM - 8:50 AM ET

158 - Combining SBRT with GM-CSF and Peg-IFNa to Induce Abscopal Effects In Previously Treated Patients with Metastatic Thymic Tumors: A Single Institution, Phase II Trial
Speaker: Fan, Min, MD, PhD - Department of Radiation Oncology, Fudan University Shanghai Cancer Center, Shanghai, Shanghai
8:40 AM - 8:50 AM ET

163 - Cross-Institutional Validation of LLM-Based Cardiac Event Extraction from Electronic Health Records
Speaker: Cao, Wenchao, PhD - Thomas Jefferson University, Philadelphia, PA
8:50 AM - 9:00 AM ET

164 - Feature Interaction-Informed Deep Radiomics for Prediction of Distant Metastasis-Free Survival in Head and Neck Cancer
Speaker: Heider, Andrew, BS - Stanford University, San Jose, CA
8:50 AM - 9:00 AM ET

Discussant
Speaker: Simone, Charles, MD, FASTRO - New York Proton Center and Memorial Sloan Kettering Cancer Center, New York, NY
8:50 AM - 9:00 AM ET

Discussant
Speaker: Chapman, Christina, MD, MS - Baylor College of Medicine, HOUSTON, TX
8:55 AM - 9:00 AM ET

Closing
Speaker: Arbab, Mona, MD, M.Ed - UT Southwestern Medical Center, Dallas, TX
8:55 AM - 9:00 AM ET

Closing
Speaker: Perlow, Haley, MD - Case Western Reserve University/University Hospitals Cleveland Medical Center, Cleveland, OH
8:55 AM - 9:00 AM ET

Closing
Speaker: Newman, Neil, MD, MS - Home, San Antonio , TX
10:45 AM - 10:55 AM ET

165 - Short-Course Radiotherapy-Based Total Neoadjuvant Therapy with or without a PD-1 Inhibitor in pMMR Locally Advanced Rectal Cancer: Short-Term Results from a Randomized Phase 3 Trial (STELLAR II)
Speaker: Tang, Yuan, MD - Cancer Hospital, Chinese Academy of Medical Sciences, Peking Union Medical College, Beijing, Beijing
10:45 AM - 10:55 AM ET

172 - Phase 2 Trial of First-Line Camrelizumab plus Concurrent Chemoradiotherapy in Patients with Nonoperative Locally Advanced Oral Squamous Cell Carcinoma: Outcomes and Toxicity Profile
Speaker: Liu, Feng, MD - Hunan Cancer Hospital, Changsha, Hunan